Translational Research Cancer Centers Consortium

Expediting Progress in Cancer Immunotherapy

__________________________________________________________________________________

About TRCCC

Check us out on Twitter!

Our Mission

Clinical Trials

__________________________________________________________________________________

TRCCC was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer.

23rd TRCCC Annual Meeting

Seven Springs Mountain Resort
Seven Spring, Pennsylvania
March 4-6, 2020

Organizing Center:

Meeting Co-Chairs:

Copyright Translational Research Cancer Centers Consortium

Weiping Zou, MD, PhD
Charles B. de Nancrede Professor of Surgery, Immunology and Biology
Co-Director, Tumor Immunology and Transplantation Biology Program

Maria G. Castro, PhD
R. C. Schneider Collegiate Professor of Neurosurgery
Professor, Cell and Developmental Biology
Director, NIH Cancer Biology Training Grant
Steering Committee Member, Woman of Color in the Academy Project (WOCAP)

The Translational Research Cancer Centers Consortium (TRCCC) mission is to gain a greater understanding of the interactions between the immune system and cancer in the setting of biologic therapy of cancer.

Annual Meeting